ALGS logo

Aligos Therapeutics (ALGS) Cash From Operations

Annual CFO

-$80.74 M
-$1.75 M-2.21%

December 31, 2024


Summary


Performance

ALGS Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALGScash flowmetrics:

Quarterly CFO

-$18.40 M
+$1.70 M+8.45%

December 31, 2024


Summary


Performance

ALGS Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALGScash flowmetrics:

TTM CFO

-$80.74 M
+$4.25 M+5.01%

December 31, 2024


Summary


Performance

ALGS TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALGScash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ALGS Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-2.2%+8.4%+5.0%
3 y3 years+30.2%+17.8%+0.7%
5 y5 years-72.7%+17.8%+0.7%

ALGS Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-2.2%+30.2%-35.2%+50.9%-15.5%+30.2%
5 y5-year-72.7%+30.2%-35.2%+50.9%-297.4%+30.2%
alltimeall time-72.7%+30.2%-35.2%+50.9%-297.4%+30.2%

Aligos Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$80.74 M(+2.2%)
-$18.40 M(-8.4%)
-$80.74 M(-5.0%)
Sep 2024
-
-$20.10 M(+3.1%)
-$85.00 M(-0.3%)
Jun 2024
-
-$19.49 M(-14.3%)
-$85.23 M(+7.4%)
Mar 2024
-
-$22.75 M(+0.4%)
-$79.36 M(+0.5%)
Dec 2023
-$79.00 M(-0.5%)
-$22.66 M(+11.4%)
-$79.00 M(+8.0%)
Sep 2023
-
-$20.34 M(+49.4%)
-$73.12 M(+4.6%)
Jun 2023
-
-$13.62 M(-39.2%)
-$69.92 M(-14.0%)
Mar 2023
-
-$22.39 M(+33.4%)
-$81.34 M(+2.5%)
Dec 2022
-$79.39 M
-$16.78 M(-2.1%)
-$79.39 M(-20.7%)
Sep 2022
-
-$17.14 M(-31.5%)
-$100.09 M(-7.6%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$25.04 M(+22.5%)
-$108.32 M(+1.9%)
Mar 2022
-
-$20.43 M(-45.5%)
-$106.30 M(-8.1%)
Dec 2021
-$115.66 M(+55.7%)
-$37.48 M(+47.7%)
-$115.66 M(+18.2%)
Sep 2021
-
-$25.37 M(+10.2%)
-$97.87 M(+9.9%)
Jun 2021
-
-$23.02 M(-22.7%)
-$89.06 M(+6.4%)
Mar 2021
-
-$29.80 M(+51.4%)
-$83.74 M(+12.8%)
Dec 2020
-$74.26 M(+58.8%)
-$19.68 M(+18.8%)
-$74.26 M(+36.1%)
Sep 2020
-
-$16.57 M(-6.4%)
-$54.58 M(+43.6%)
Jun 2020
-
-$17.69 M(-12.9%)
-$38.01 M(+87.1%)
Mar 2020
-
-$20.32 M
-$20.32 M
Dec 2019
-$46.77 M
-
-

FAQ

  • What is Aligos Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Aligos Therapeutics?
  • What is Aligos Therapeutics annual CFO year-on-year change?
  • What is Aligos Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Aligos Therapeutics?
  • What is Aligos Therapeutics quarterly CFO year-on-year change?
  • What is Aligos Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Aligos Therapeutics?
  • What is Aligos Therapeutics TTM CFO year-on-year change?

What is Aligos Therapeutics annual cash flow from operations?

The current annual CFO of ALGS is -$80.74 M

What is the all time high annual CFO for Aligos Therapeutics?

Aligos Therapeutics all-time high annual cash flow from operations is -$46.77 M

What is Aligos Therapeutics annual CFO year-on-year change?

Over the past year, ALGS annual cash flow from operations has changed by -$1.75 M (-2.21%)

What is Aligos Therapeutics quarterly cash flow from operations?

The current quarterly CFO of ALGS is -$18.40 M

What is the all time high quarterly CFO for Aligos Therapeutics?

Aligos Therapeutics all-time high quarterly cash flow from operations is -$13.62 M

What is Aligos Therapeutics quarterly CFO year-on-year change?

Over the past year, ALGS quarterly cash flow from operations has changed by +$1.70 M (+8.45%)

What is Aligos Therapeutics TTM cash flow from operations?

The current TTM CFO of ALGS is -$80.74 M

What is the all time high TTM CFO for Aligos Therapeutics?

Aligos Therapeutics all-time high TTM cash flow from operations is -$20.32 M

What is Aligos Therapeutics TTM CFO year-on-year change?

Over the past year, ALGS TTM cash flow from operations has changed by +$4.25 M (+5.01%)